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Abstract 
 
Aim: Aim of the present study was to evaluate whether natural fertility is related to serum 25-
hydroxyvitamin D levels. 
Methods: A nested case-control study was designed from a prospective cohort of pregnant women 
undergoing first trimester screening for aneuploidies. Cases were women seeking pregnancy for 12-
24 months. Controls were the subsequent age-matched women conceiving in less than one year. We 
excluded women aged ≥ 40 years or < 18 years, those assuming supplementary products that 
included vitamin D before or during pregnancy, those with irregular menstrual cycles or known 
causes of subfertility, those conceiving through assisted reproductive techniques or requiring 
ovarian stimulation and those who were overweight or obese. A quantitative detection of serum 25-
hydroxyvitamin D and patients’ interview were performed. 
Results: Seventy-three cases and 73 matched controls were selected. The mean ± SD serum 25-
hydroxyvitamin D was 21.2 ± 6.8 and 19.7 ± 7.3 ng/ml, respectively (p=0.16). The number (%) of 
women with serum levels < 20 ng/ml (vitamin D insufficiency) was 34 (47%) and 37 (51%), 
respectively (p=0.73). The adjusted OR of longer time to pregnancy in women with vitamin D 
insufficiency was 0.84 (95%CI: 0.42-1.66). 
Conclusions: Our study does not support a crucial role of 25-OH-vitamin D in natural fertility.  
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Introduction  
There is growing evidence that vitamin D influences reproductive mechanisms in human [1-3]. In 
rodents, animals knock-out for the Vitamin D receptor and those fed with vitamin D deficient diet 
have a reduced fertility [4]. However, up to now, data in human is not univocal. Some authors 
reported worse oocyte competence and embryo implantation in women with deficient serum levels 
of vitamin D undergoing IVF [5-8] but others did not [9-12]. Interventional studies testing the 
potential benefits of vitamin D supplementation prior to IVF are ongoing but yet unavailable [13]. 
IVF is a valuable and largely used model to investigate factors affecting fertility in women. It 
provides reliable data on oocyte quality and embryo implantation. However, IVF may not properly 
reveal all the potential detrimental effects of vitamin D deficiency on natural fertility. Of potential 
relevance here is the impact on the cervix function, the sperm transport (and possibly function), the 
tubal function and the endocrinological feedbacks. For this reason, we deemed valuable to 
investigate the impact of serum levels of vitamin D on natural fecundity. To elucidate this aspect,  
we evaluated whether serum levels of 25-hydroxyvitamin D (25-OH-vitamin D), the form of 
vitamin D reflecting the store of the vitamin, may affect time to natural pregnancy. To this aim, we 
recruited natural pregnant women referring for routine first trimester screening for aneuploidies and 
compared serum levels of 25-OH-Vitamin D in those who achieved pregnancy in less or more than 
one year.  
 
Materials and methods 
Women referring to our Institution for routine first trimester screening for aneuploidies (11
+0
-12
+6
 
weeks of gestation) since January 2012 were invited to participate to a large prospective study 
ultimately aimed at assessing the impact of vitamin D levels on fertility and obstetrical 
complications. The program of aneuploidies screening is open to any woman age in our Institution 
but, for this nested case-control study, we excluded women aged ≥ 40 years (to reduce the 
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confounding effect of older age) or < 18 years. Moreover, we excluded those assuming 
supplementary products that included vitamin D before or during pregnancy, those with irregular 
menstrual cycles or known causes of subfertility (male factor, tubal factor or endometriosis), those 
conceiving through assisted reproductive techniques or requiring ovarian stimulation and those who 
were overweight or obese (BMI > 25 Kg/m
2
). Cases were women who sought pregnancy for 12-24 
months. Controls corresponded to the following age-matched women who become pregnant in less 
than one year. A matched design and analysis was decided to overcome the important impact of age 
and seasonality. Women agreeing to participate provided a blood sample. Blood samples were 
allowed to clot at room temperature and then centrifuged at 2,000 g for 10 minutes. The resulting 
serum was stored at -20 °C until assayed. The assessments were performed in three distinct 
experiments thawing a similar number of matched case-controls. The quantitative detection of total 
25-OH-vitamin D levels was performed using a commercially available kit based on a 
chemiluminescence technology (DiaSorin). The intra- and inter-assay coefficients of variations 
were below 10% and 15%, respectively. Vitamin D insufficiency and deficiency corresponded to 
serum levels of 25-OH-vitamin D <20 ng/ml and <10 ng/ml, respectively [14]. 
Statistical analyses were performed using SPSS 18.0 software (Chicago, IL.). Data was compared 
using unpaired or paired Student-t test, non-parametric Wilcoxon test, Fisher Exact test or 
McNemar test, as appropriate. P values below 0.05 were considered statistically significant. A 
logistic regression analysis including variables found to differ at univariate analysis was used to 
calculate the adjusted Odds Ratio (OR). The sample size was calculated based on a paired study 
design, setting type I and II errors at 0.05 and 0.20, respectively, assuming as clinically relevant a 
15% reduction in serum 25-OH-vitamin D in cases (thus from the expected 20 ng/ml to 17 ng/ml) 
and referring to an expected SD of the difference when matching for study period of 9 ng/ml, as 
calculated on our own preliminary data [15]. On these bases, we calculated that 73 cases and 73 
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controls were necessary. The adequate number of women to be recruited was fulfilled within June 
2013. 
 
Results 
Baseline characteristics of the 146 included women are shown in Table 1. As a consequence of not 
reassuring/positive results of the screening test, invasive prenatal diagnosis was requested by 6 (8%) 
and 4 (5%) women among cases and controls, respectively (p=0.75). One woman aged 35 years 
belonging to the group of controls had a definite diagnosis of aneuploidy and a spontaneous 
abortion (p=1.00). The rate of obstetrics complications in cases (n=73) and controls (n=72) were 
mostly similar. Preterm birth occurred in 8 (11%) and 8 (11%) women (p=1.00), hypertensive 
disorders in 6 (8%) and 8 (11%) women (p=0.59), gestational diabetes mellitus in 6 (8%) and 5 
(7%) women (p=1.00) and cesarean delivery was required in 27 (37%) and 26 (36%) women 
(p=1.00), respectively. Excluding the three twin pregnancies, the newborn weights resulted also 
similar (3,248 ± 593 g and 3,304 ± 348 g, respectively, p=0.49).  
Serum 25-OH-vitamin D does not differ between cases and controls (Figure 1). The mean ± SD was 
21.2 ± 6.8 and 19.7 ± 7.3 ng/ml, respectively (paired t-test, p=0.16; unpaired t-test p=0.20). The 
mean (95%CI) difference was + 1.5 (-0.6 / +3.6) ng/ml for cases compared to controls. The number 
(%) of women with serum levels < 20 ng/ml was 34 (47%) and 37 (51%), respectively (McNemar 
test, p=0.73; Fisher Exact test, p=0.74). The OR of longer time to pregnancy in women with vitamin 
D insufficiency was 0.85 (95%CI: 0.44-1.62). The OR adjusted for men age and parity was 0.84 
(95%CI: 0.42-1.66). The number (%) of women with serum levels <10 ng/ml was 3 (4%) and 6 
(8%), respectively (McNemar test, p=0.45; Fisher Exact test, p=0.49). The crude and adjusted ORs 
of subfertility in women with vitamin D deficiency was 0.48 (95%CI: 0.12-1.99) and 0.70 (95%CI: 
0.15-2.95), respectively. Correlation for the whole population (n=146) between time to pregnancy 
and serum 25-OH-vitamin D was unremarkable (Pearson R
2
=2%, p=0.07). The analyses were 
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repeated excluding the woman who had a spontaneous abortion (and her matched case) but results 
were extremely similar (data not shown) 
 
Discussion 
Our results contrast with the available emerging evidence suggesting a detrimental effect of vitamin 
D deficiency on woman fertility. They are however in agreement with a recent study comparing 
women who did or did not conceive naturally within six months [16]. Our data is more robust in 
this regard considering that a threshold of 12 months is generally considered more appropriate to 
define a condition of difficulty in conception [17]. Our study design may be at prima faces arguable 
because we recruited both cases and controls among pregnant women. In this regard, it has however 
to be highlighted that time to pregnancy is widely used in the literature to investigate factors that 
may influence fertility. This outcome was used in pivotal studies evaluating whether fertility varied 
over historical periods [18] and demonstrating the detrimental effect of several factors including 
women age, male age, obesity and smoking [19]. Noteworthy, time to pregnancy was also used to 
sort out the currently used WHO reference ranges for semen [20,21]. The main advantage of this 
study design is preventing confounders. Accordingly, in our study, recorded baseline characteristics 
of cases and controls were similar with the expected exceptions of men age and parity [19].  
On the other hand, we believe that some caution is warranted prior to definitely conclude for a lack 
of an association between vitamin D insufficiency and infertility for the following reasons. Firstly, 
serum levels of 25-OH-vitamin D were generally low in both cases and controls. Only a small 
minority of women (7 cases and 7 controls, data not analyzed) have actually levels above the 
recommended optimal threshold of 30 ng/ml [22]. In other worlds, our population allowed us to 
assess whether very low levels could prolong time to pregnancy but did not consent us to assess 
whether appropriate serum 25-OH-vitamin D levels would shorten time to pregnancy. Secondly, 25-
OH-vitamin D varies during the year. This should not have markedly affected our conclusions since 
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serum levels of the vitamin were shown to remain mainly stable over time relative to other members 
of a population. Large cohort studies that have monitored 25-OH-vitamin D indeed showed that 
those who are low (or high) at baseline tend to remain low (or high) during multiyear follow-up 
[23-25]. On the other hand, it has to be recognized that an optimal (but complex and very costly) 
study design would be to prospectively recruit women seeking pregnancy and to regularly monitor 
serum 25-OH-vitamin D. Thirdly, the pathogenetic mechanisms linking vitamin D to fertility have 
not yet been clarified. It cannot be excluded that adequate levels may be of relevance only in 
particular subgroups of women to compensate for other insufficiencies. If so, our study would be 
underpowered. Noteworthy, since women were recruited at the end of the first trimester, our data is 
not informative on the risk of miscarriage. Fourthly, one may claim that pregnancy-related 
modifications may have diluted the differences. Serum 25-OH-vitamin D may modify during initial 
pregnancy and women habits may also change. However, we do not estimate that this may have 
significantly impacted on our results. Indeed, available data did not show significant change of 
serum 25-OH-vitamin D with the advent of pregnancy [16]. Moreover, even if some dietary 
changes at the beginning of pregnancy are likely, there is no reason to hypothesize significant 
changes in sun exposure habits during initial pregnancy. Noteworthy, vitamin D reserve is for the 
most part due to sun exposure (90%) compared to dietary intake (10%) [26]. Finally, even if serum 
levels would be influenced by the onset of pregnancy, this confounder is expected to have a similar 
impact in the two study groups. 
Overall, our study does not support a crucial role of 25-OH-vitamin D in natural fertility. Further 
studies and in particular interventional RCTs are however warranted to draw definite conclusions. 
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Figure legend 
 
Figure 1: Serum levels of 25-OH-vitamin D in subfertile (black columns) and fertile (grey 
columns) women according to study period. None of the tested differences resulted statistically 
significant. 
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Table 1.  General characteristics of women with subfertility (cases) and controls. 
    
Characteristics 
Cases Controls 
p 
n=73 n=73 
    
Woman age (years) 32.8 ± 3.7  32.7 ± 3.8 0.96 
Partner age (years) 36.6 ± 4.9 35.0 ± 4.0 0.04 
BMI (Kg/m2) 22.1 ± 3.4 21.8 ± 3.4 0.62 
Ethnicity   1.00 
Caucasian 70 (96%) 71 (97%)  
Other 3 (4%) 2 (3%)  
Marital status   0.72 
Married 51 (70%) 48 (66%)  
Unmarried 22 (30%) 23 (34%)  
Scholarity   0.42 
                Elementary-middle school 11 (15%) 6 (8%)  
High School 29 (40%) 33 (45%)  
College-university 31 (42%) 34 (47%)  
Previous pregnancies 31 (42%) 37 (51%) 0.41 
Previous live births 13 (18%) 26 (36%) 0.02 
Menstrual cycle lenght (days) 28 ± 2 29 ± 2 0.64 
Smoking prior to pregnancy 16 (22%) 11 (15%) 0.39 
Twin pregnancy 1 (1%) 2 (3%) 1.00 
Gestational age at first trimester screening (weeks) 11.5 ± 0.5 11.6 ± 0.6 0.34 
    
Data is presented as mean ± SD or Number (%) as appropriate.   
P values from unpaired comparisons are reported.   
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